Dermata Therapeutics, Inc. ( DRMAW) - Key Metrics
Stock symbol DRMAW is outdated, potentially delisted? Maybe it is available on other exchange?
DRMAW Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.74 | -$0.60 | -$0.63 |
| 2026Q1 | $0 | -$0.48 | -$0.64 | -$0.64 |
| 2025Q4 | $0 | -$1.52 | -$1.09 | -$1.09 |
| 2025Q3 | $0 | -$1.65 | -$1.76 | -$1.76 |
| 2025Q2 | $0 | -$1.66 | -$2.62 | -$2.62 |
DRMAW Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.44 |
| 2026Q1 | 0% | -0.63 |
| 2025Q4 | 0% | -0.38 |
| 2025Q3 | 0% | -0.76 |
| 2025Q2 | 0% | -0.88 |
DRMAW
Price: $0
52 week price:
Earnings Per Share: -2.16 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 203
Market Capitalization: 409